QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold

Germantown, Maryland, and Hilden, Germany, May 22, 2018 – QIAGEN today welcomed the First Edition of the World Health Organization’s (WHO) Essential Diagnostics List, which endorses the use of interferon gamma release assays (IGRAs) for the diagnosis of latent TB infection. The inclusion on the list comes as the WHO and other organizations like the... Read more

Cleveland Clinic and Brooks Automation Announce New Biobanking Facility

May 21, 2018 Press Releases Research Foundation Basic Research Sample Management New facility increases Clinic’s capacity to analyze patient samples, advance medical research and enhance clinical care Chelmsford, Mass., and Cleveland, Ohio – May 21, 2018 – Cleveland Clinic and Brooks Automation. Inc. (Nasdaq: BRKS) will launch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of... Read more

Precipio Announces Preliminary Q1 2018 Year-Over-Year Revenue Increase of 286%

Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited 1st quarter 2018 revenues of approximately $712,000, representing a 286% increase from the same quarter in the prior year. Drivers of revenue growth that have been... Read more

GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital

BOSTON – May 9, 2018 – GE Healthcare (NYSE:GE) is working with Preventice Solutions to provide customers with an extension of the hospital heart station and to expand GE Healthcare ECG services into the home, creating a more holistic solution for monitoring ambulatory ECG patients. The collaboration offers a unified solution to providing in-hospital ECG,... Read more

Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners

Funding supports company’s mission to launch a medical discovery platform and engage a global community of data contributors   SAN DIEGO, May 8, 2018 /PRNewswire/ — Luna DNA, the first community-owned genomic and medical research database, today announced financing from key investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader... Read more

Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences, Inc.

08. May 2018 Greiner Bio-One Magnetic 3D Cell Culture Products Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Magnetic 3D... Read more

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 08 May 2018 Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting New and updated pivotal combination data from the Tecentriq lung programme, including overall survival (OS) results from IMpower150 and progression free survival (PFS) results from IMpower131 New, longer follow-up data... Read more

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 08 May 2018 Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting New and updated pivotal combination data from the Tecentriq lung programme, including overall survival (OS) results from IMpower150 and progression free survival (PFS) results from IMpower131 New, longer follow-up data... Read more

Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing

Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing Fully automated CISH and IQFISH panel for lymphoma combines multiple innovations SANTA CLARA, Calif., April 26, 2018 Agilent Technologies Inc. (NYSE: A) today announced an expansion of its portfolio of in situ hybridization probes with the release of its EBER RNA CISH, Kappa, and... Read more